Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.55 |
| ▸ | APP | P05067 | 1/20 | 0.55 |
| ▸ | GRM5 | P41594 | 5/20 | 0.51 |
| ▸ | ASIC3 | Q9UHC3 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | HNF4A | P41235 | 1/20 | 0.44 |
| ▸ | COMT | P21964 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5886608 | 0.88 | APP (0.71) | CYP1A1CYP1A2CYP1B1KCNH2APP | |
| Methane SCHEMBL28739770 | 0.85 | APP (0.67) | CYP1A1CYP1A2CYP1B1KCNH2APP | |
| SCHEMBL5949303 | 0.85 | APP (0.75) | CYP1A1CYP1A2CYP1B1KCNH2APP | |
| SCHEMBL4324850 | 0.84 | ASIC3 (0.53) | KCNH2APPGRM5ASIC3COMT | |
| SCHEMBL2295150 | 0.83 | APP (0.63) | CYP1A1CYP1A2CYP1B1KCNH2APP | |
| Diphenylacetylene SCHEMBL27926128 | 0.83 | APP (0.80) | CYP1A1CYP1A2CYP1B1KCNH2APP | |
| Diphenylacetylene SCHEMBL21271527 | 0.83 | APP (0.80) | CYP1A1CYP1A2CYP1B1KCNH2APP | |
| SCHEMBL4369819 | 0.81 | APP (0.60) | CYP1A1CYP1A2CYP1B1KCNH2APP | |
| SCHEMBL28255391 | 0.80 | FFAR1 (0.48) | CYP1A1CYP1A2CYP1B1KCNH2GRM5 | |
| SCHEMBL6364777 | 0.80 | APP (0.75) | CYP1A2KCNH2APPGRM5ASIC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100222432-A1 | Synthetic Carbon Nanotubes | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION | 2010-09-02 | — | — | US | disclosed |
| WO-2008048227-A2 | SYNTHETIC CARBON NANOTUBES | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2008-04-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222432-A1 | Synthetic Carbon Nanotubes | CYCS, CHN2, TUBA3C | CYP1A1 2947/4885CYP1A2 3671/4885CYP1B1 3684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.